Radial Research【RAD】銘柄情報

Radial Research Corp (RAD) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

0.135

( - )

買値

0.095

売値

0.135

出来高

0.00 日の範囲 0.00

0.005 52 週間の範囲 0.195

時価総額

375.815k

前日終値

0.135

始値

時刻

0.135

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

$ 9,982

発行済株式数

2,783,818

配当利回り

PER

-2

1 株当たり利益 (EPS)

-0.05

歳入

純利益

-132.36k

Radial Research Corp. operates as a technology company in Canada. The company develops online and download technologies and services, including software, websites, and smartphone applications. Its projects include Zoompages, an e-commerce sales funnel content management system; The Commuter, a trip ... Radial Research Corp. operates as a technology company in Canada. The company develops online and download technologies and services, including software, websites, and smartphone applications. Its projects include Zoompages, an e-commerce sales funnel content management system; The Commuter, a trip planning application; Good Inc, a mobile application for pet donations; Rental Platform, a rent platform website and mobile application; and Trill Bank, a banking system. Radial Research Corp. was incorporated in 2017 and is based in Vancouver, Canada. 詳細を表示

セクター

Technology

業界

Software & It Services

ウェブサイト

radial-research.com

本社

Vancouver, Canada

設立

2026

Radial Research Corp is listed in the Technology sector of the Canadian Securities Exchange with ticker RAD. The last closing price for Radial Research was $0.14. Over the last year, Radial Research shares have traded in a share price range of $ 0.005 to $ 0.195.

Radial Research currently has 2,783,818 shares in issue. The market capitalisation of Radial Research is $375,815.43 . Radial Research has a price to earnings ratio (PE ratio) of -2.00.

Radiopharm Theranostics Reports Business Update

Completed enrolment in Phase 2b clinical trial of imaging agent RAD 101 in patients with recurrent brain...

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

177Lu-RAD202 demonstrated encouraging tumor uptake and a favorable safety profile in the lowest dose cohort ...

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases

Interim data to date showed 90% concordance with MRI (the primary endpoint) Clinical trial readout (Primary...

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

SYDNEY, April 08, 2026 (GLOBE NEWSWIRE) -- Radiopharm Theranostics (ASX: RAD, Nasdaq: RADX, “Radiopharm” or...

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Data from the interim analysis in Phase 2b trial of RAD101 showed significant and selective tumor uptake in...

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

On track to share data from first two dose levels in 2H 2026 Targeting KLK3 and leveraging the dual emission...

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

90% of patients dosed with RAD 101 and evaluable at interim analysis achieved concordance with MRI imaging (the...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.04	42.1052631579	0.095	0.135	0.095	300	0.12166667	CS
4	0.045	50	0.09	0.155	0.09	733	0.13463281	CS
12	0.06	80	0.075	0.195	0.075	4144	0.11595202	CS
26	0.125	1250	0.01	0.195	0.005	10709	0.02996273	CS
52	0.115	575	0.02	0.195	0.005	17396	0.01332994	CS
156	0.125	1250	0.01	0.195	0.005	7064	0.01338825	CS
260	0.055	68.75	0.08	0.195	0.005	5884	0.0170458	CS

RAD - Frequently Asked Questions (FAQ)

What is the current Radial Research Corp share price?

The current share price of Radial Research Corp is $ 0.135

How many Radial Research Corp shares are in issue?

Radial Research Corp has 2,783,818 shares in issue

What is the market cap of Radial Research Corp?

The market capitalisation of Radial Research Corp is CAD 375.82k

What is the 1 year trading range for Radial Research Corp share price?

Radial Research Corp has traded in the range of $ 0.005 to $ 0.195 during the past year

What is the PE ratio of Radial Research Corp?

The price to earnings ratio of Radial Research Corp is -2

What is the registered address of Radial Research Corp?

The registered address for Radial Research Corp is 890 West Pender Street, Vancouver, British Columbia, V6C 1J9

What is the Radial Research Corp website address?

The website address for Radial Research Corp is radial-research.com

Which industry sector does Radial Research Corp operate in?

Radial Research Corp operates in the Software & IT Services sector

市場データ

ニュース

投資ツール

市場

発見

Hot Features

Follow Feed

ライブオプションフロー

モニター

Radial Research Corp (RAD)

Radial Research Corp (RAD) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

Radial Research Corp について

RAD 最新ニュース

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)

Radiopharm Theranostics Reports Half-Year Financial Results and Business Updates

RAD Increases Ownership in Radiopharm Ventures to 87.5%

Radiopharm Theranostics Reports Business Update

Radiopharm Theranostics Presents Initial Findings from Phase 1 First-in-Human HEAT Clinical Trial for 177Lu-RAD202 in HER2+ Solid Tumors at American Association for Cancer Research 2026

Radiopharm Theranostics Completes Enrollment in U.S. Phase 2b Imaging Trial of RAD 101 for Diagnosis of Brain Metastases

Radiopharm Theranostics Advances to Cohort 3 in 177Lu-RAD202 Phase 1 Dose Escalating Clinical Trial

Radiopharm Theranostics and Siemens Healthineers Sign Clinical Supply Agreement for RAD101 in the U.S.

Radiopharm Theranostics Doses First Patient in Phase 1 Clinical Study of RAD 402 in Advanced Prostate Cancer

Radiopharm Theranostics Achieves Primary Endpoint In 90% of Patients At Second Interim Analysis of RAD 101 Phase 2b Imaging Trial in Brain Metastases

Radiopharm Theranostics Doses First Patient in Phase 1/2a Clinical Study of BetaBart (RV-01)

RAD - Frequently Asked Questions (FAQ)

RAD 取引

議論

最近閲覧した銘柄

会社情報

ビジネス

人気

アプリを入手

無料で登録してください:

広告を削除する